Mycotopia Therapies, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Mycotopia Therapies, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Mycotopia Therapies, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$460K, a 49.1% decline year-over-year.
  • Mycotopia Therapies, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$1.65M, a 10.3% decline year-over-year.
  • Mycotopia Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$1.18M, a 54.8% increase from 2022.
  • Mycotopia Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.61M, a 49.2% increase from 2021.
  • Mycotopia Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$5.14M, a 31958% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.65M -$460K -$151K -49.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$1.5M -$471K -$192K -68.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$1.3M -$426K -$123K -40.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$1.18M -$291K +$313K +51.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-23
Q3 2023 -$1.49M -$309K -$16.1K -5.49% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$1.48M -$279K +$132K +32.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$1.61M -$303K +$1M +76.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$2.61M -$604K +$2.03M +77.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-23
Q3 2022 -$4.65M -$293K +$2.09M +87.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$6.74M -$411K -$304K -283% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$6.44M -$1.3M -$1.3M -15734% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$5.14M -$2.64M -$2.63M -33975% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-11-06
Q3 2021 -$2.51M -$2.39M -$2.38M -36701% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-11-06
Q2 2021 -$130K -$107K -$106K -6410% Apr 1, 2021 Jun 30, 2021 10-Q/A 2023-11-06
Q1 2021 -$24.1K -$8.24K -$8.08K Jan 1, 2021 Mar 31, 2021 10-Q/A 2023-11-06
Q4 2020 -$16K -$7.74K Oct 1, 2020 Dec 31, 2020 10-K/A 2023-10-17
Q3 2020 -$6.48K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-19
Q2 2020 -$1.65K Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-19
Q1 2020 -$157* Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.